NIH Notices

  • Notice of Information Regarding the “Announcement of Antimicrobial Resistance Rapid, Point-of-Need Diagnostic Test Challenge Competition”
    (NOT-OD-17-063) National Institutes of Health
  • NIH and FDA Release Protocol Template for Phase 2 and 3 IND/IDE Clinical Trials
    (NOT-OD-17-064) National Institutes of Health
  • Notice of Information: Alignment Among the Disease Definitions Utilized to Govern Genetic and Genomic Data Sharing for Studies Involving Alzheimer’s Disease
    (NOT-AG-17-007)
    National Institute on Aging
    National Institute of Neurological Disorders and Stroke
  • Notice of Intent to Publish a Funding Opportunity Announcement for NCCIH Natural Product Early Phase Clinical Trials (R33)
    (NOT-AT-17-011)
    National Center for Complementary and Integrative Health
  • Notice of NCI’s Participation on PA-17-226, Advancing the Science of Geriatric Palliative Care (R21)
    (NOT-CA-17-055)
    National Cancer Institute
  • Notice of Correction to Key Dates for PAR-16-201 ” Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R21)”
    (NOT-CA-17-056)
    National Cancer Institute
  • Notice of Change in the Expiration Date for PAR-15-119 “NIDA Mentored Clinical Scientists Development Program Award in Drug Abuse and Addiction (K12)”
    (NOT-DA-17-030)
    National Institute on Drug Abuse
  • Notice of Change in the Expiration Date for PA-15-002 “Epidemiology of Drug Abuse (R03)”
    (NOT-DA-17-031)
    National Institute on Drug Abuse
  • Notice of Change in the Expiration Date for PA-15-001 Epidemiology of Drug Abuse (R21)
    (NOT-DA-17-032)
    National Institute on Drug Abuse
  • Notice of Change in the Expiration Date for PA-15-003 Epidemiology of Drug Abuse (R01)
    (NOT-DA-17-033)
    National Institute on Drug Abuse
  • Notice of Change in the Expiration Date for PA-15-081 Drug Abuse Prevention Intervention Research (R03)
    (NOT-DA-17-036)
    National Institute on Drug Abuse
  • Notice of Reissuance of the “Modeling of Infectious Disease Agent Study Research Projects (R01)” Funding Opportunity Announcement
    (NOT-GM-17-006)
    National Institute of General Medical Sciences
    National Institute of Allergy and Infectious Diseases
  • Notice of Change in PAR-17-045 “Focused Technology Research and Development (R01)”
    (NOT-GM-17-007)
    National Institute of General Medical Sciences
  • Notice of Change in PAR-17-046 “Exploratory Research for Technology Development (R21)”
    (NOT-GM-17-008)
    National Institute of General Medical Sciences
  • Notice of Cancellation of Two Application Due Dates for NHLBI RFA-HL-17-015 “Bold New Bioengineering Methods and Approaches for Heart, Lung, Blood and Sleep Disorders and Diseases (R21)”
    (NOT-HL-17-511)
    National Heart, Lung, and Blood Institute
  • Notice of Frequently Asked Questions for RFA-HL-18-020 Integrative Computational Biology for Analysis of NHLBI TOPMed Data (R01)
    (NOT-HL-17-513)
    National Heart, Lung, and Blood Institute
  • Notice of Correction to PAR-17-179 ” From Genomic Association to Causation: A Convergent Neuroscience Approach for Integrating Levels of Analysis to Delineate Brain Function in Neuropsychiatry (U01)”
    (NOT-MH-17-021)
    National Institute of Mental Health
  • Notice of Correction to PAR-17-176 “From Genomic Association to Causation: A Convergent Neuroscience Approach for Integrating Levels of Analysis to Delineate Brain Function in Neuropsychiatry (Collaborative U01)”
    (NOT-MH-17-022)
    National Institute of Mental Health
  • Notice of Change of the Components of Participating Organizations for RFA-RM-17-005 NIH Director’s Pioneer Award Program (DP1)
    (NOT-RM-17-026)
    NIH Roadmap Initiatives
    The Common Fund/Office of Strategic Coordination
  • Notice of Change of the Components of Participating Organizations for RFA-RM-17-006 NIH Director’s New Innovator Award Program (DP2)
    (NOT-RM-17-027)
    NIH Roadmap Initiatives
  • Notice of Change of the Components of Participating Organizations for RFA-RM-17-007 NIH Director’s Transformative Research Awards (R01)
    (NOT-RM-17-028)
    NIH Roadmap Initiatives
  • Notice of Change of the Components of Participating Organizations for RFA-RM-17-008 NIH Director’s Early Independence Awards (DP5)
    (NOT-RM-17-029)
    NIH Roadmap Initiatives
  • Notice of NCATS Participation in RFA-HL-17-025 “Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (U54)”
    (NOT-TR-17-016)
    National Center for Advancing Translational Sciences
Advertisements
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s